NABRIVA THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NBRVF and buy or sell other stocks, ETFs, and their options commission-free!About NBRVF
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
CEOH. Michael Hogan
CEOH. Michael Hogan
Employees39
Employees39
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees39
Employees39
NBRVF Key Statistics
Market cap646.17
Market cap646.17
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume141.90
Average volume141.90
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0002
52 Week high$0.0002
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 646.17, NABRIVA THERAPEUTICS(NBRVF) trades at $0.00.
On 2026-04-22, NABRIVA THERAPEUTICS(NBRVF) stock opened at —, reached a high of —, and a low of —.
NABRIVA THERAPEUTICS(NBRVF) shares are trading with a volume of 0, against a daily average of 141.9.
In the last year, NABRIVA THERAPEUTICS(NBRVF) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, NABRIVA THERAPEUTICS(NBRVF) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
Analyst ratings
83%
of 6 ratingsBuy
16.7%
Hold
83.3%
Sell
0%
People also own
Based on the portfolios of people who own NBRVF. This list is generated using Robinhood data, and it’s not a recommendation.